Company intelligence / Profile preview

Estill Advisory Group

New York, New York, United States

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Estill Advisory Group is a boutique investment banking and strategic advisory firm focused on growth companies in the healthcare sector. The firm provides advisory services across mergers and acquisitions, divestitures, licensing transactions, strategic partnerships, and capital raises. It appears to serve management teams, boards, and institutional investors rather than developing therapeutics or operating a drug pipeline itself. Based on available public information, Estill Advisory Group is a healthcare-focused financial advisory business rather than a biotech, pharma, CRO, or therapeutic product company.

Industry: Consulting

Beyond the preview

Go deeper on Estill Advisory Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Estill Advisory Group.

Explore the full profile